Postinfarct cardiac remodeling and ventricular arrhythmias

Myocardial Ischemia: Causes, Symptoms and Treatment

Volumn , Issue , 2010, Pages 269-277

  Sovari, Ali A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052439839     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. Thygesen, K; Alpert, JS; White, HD; et al. Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J., 2007 Oct, 28(20), 2525-38.
2. Frantz, S; et al. Post-infarct remodeling: contribution of wound healing and inflammation. Cardiovascular research, 2009, 81, 474-481.
3. Seddon, M; Looi, YH; Shah, AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart, 2007, 93, 903-907.
4. Fukui, T; Yoshiyama, M; Hanatani, A; Omura, T; Yoshikawa, J; Abe, Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem Biophys Res Commun, 2001, 281, 1200-1206.
5. Sun, Y. Myocardial repair/remodeling following infarction: roles of local factors. Cardiovascular research, 2009 (81), 482-490.
6. Kabe, Y; Ando, K; Hirao, S; et al. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antiox Redox Signal, 2005, 7, 395-403.
7. Schoonbroodt, S; Piette, J. Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol, 2000, 15, 1075-1083.
8. Grieve, DJ; Byrne, JA; Cave, AC; Shah, AM. Role of oxidative stress in cardiac remodeling after myocardial infarction. Heart Lung Circ, 2004, 13, 132-138.
9. Sun, Y; Weber, KT. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res, 1996, 31, 518-525.
10. Falkenhahn, M; Franke, F; Bohle, RM; Zhu, YC; Stauss, HM; Bachmann, S; et al. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension, 1995, 25, 219-226.
11. Touyz, RM; Tabet, F; Schiffrin, EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol, 2003, 30, 860-866.
12. Desmoulie’re, A; Geinoz, A; Gabbiani, F; Gabbiani, G. Transforming growth factorbeta1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol, 1993, 122, 103-111.
13. Sovari, AA; et al. Serum transforming growth factor-beta 1 as a risk stratifier of sudden cardiac death. Med Hypotheses., 2008 Aug, 71(2), 262-5.
14. Desmoulie’re, A; Gabbiani, G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: R. A. F. Clark (Ed.), The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York: Plenum Press; 1996, 391-423.
15. Katwa, LC; Campbell, SE; Tyagi, SC; Lee, SJ; Cicila, GT; Weber, KT. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol, 1997, 29, 1375-1386.
16. Gray, MO; Long, CS; Kalinyak, JE; Li, HT; Karliner, JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res, 1998, 40, 352-63.
17. Campbell, SE; Katwa, LC. Angiotensin II stimulated expression of transforming growth factor-beta 1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol, 1997, 29, 1947-58.
18. Lee, AA; Dillmann, WH; McCulloch, AD; Villarreal, FJ. Angiotensin II stimulates the autocrine production of transforming growth factor beta1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol, 1995, 27, 2347-57.
19. Everett, AD; Tufro-McReddie, A; Fisher, A; Gomez, RA. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension, 1994, 23, 587-92.
20. Iglesias-De La Cruz, MC; Ruiz-Torres, P; Alcamı', J; Dı‘ez-Marque’s, L; Ortega-Vela’zquez, R; Chen, S; et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int, 2001, 59, 87-95.
21. Beresewicz, A; Horackova, M. Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms. J Mol Cell Cardiol, 1991, 23, 899-918.
22. Song, Y; Shryock, JC; Wagner, S; Maier, LS; Belardinelli, L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther, 2006, 318, 214-222.
23. Thomas, GP; Sims, SM; Cook, MA; Karmazyn, M. Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. J Pharmacol Exp Ther, 1998, 286, 1208-1214.
24. Hinata, M; Matsuoka, I; Iwamoto, T; Watanabe, Y; Kimura, J. Mechanism of Na+/Ca2+ exchanger activation by hydrogen peroxide in guinea-pig ventricular myocytes. J Pharmacol Sci, 2007, 103, 283-292.
25. Morris, TE; Sulakhe, PV. Sarcoplasmic reticulum Ca(2+)-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic Biol Med, 1997, 22, 37-47.
26. Anzai, K; Ogawa, K; Kuniyasu, A; Ozawa, T; Yamamoto, H; Nakayama, H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem Biophys Res Commun, 1998, 249, 938-942.
27. Ono, N; Hayashi, H; Kawase, A; et al. Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition. AmJ Physiol, 2007, 292, H639-H648.
28. Kaibara, M; Mitarai, S; Yano, K; et al. Involvement of Na_-H_ antiporter in regulation of L-type Ca2_ channel current by angiotensin II in rabbit ventricular myocytes. Circ Res, 1994, 75, 1121-1125.
29. Quignard, JF; Mironneau, J; Carricaburu, V; et al. Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J Biol Chem, 2001, 276, 32545-32551.
30. Yu, H; Gao, J; Wang, H; et al. Effects of the renin-angiotensin system on the current Ito in epicardial and endocardial ventricular myocytes from the canine heart. Circ Res, 2000, 86, 1062-1068.
31. Caballero, R; Gomez, R; Moreno, I; et al. Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current. Cardiovasc Res, 2004, 62, 86-95.
32. Benitah, JP; Vassort, G. Aldosterone upregulates Ca2_ current in adult rat cardiomyocytes. Circ Res, 1999, 85, 1139-1145.
33. Benitah, JP; Perrier, E; Gomez, AM; et al. Effects of aldosterone on transient outward K_ current density in rat ventricular myocytes. J Physiol, 2001, 537, 151-160.
34. Miragoli, M; Salvarani, N; Rohr, S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res., 2007 Oct 12, 101(8), 755-8.
35. Ono, N; Hayashi, H; Kawase, A; et al. Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition. Am J Physiol Heart Circ Physiol, 2007, 292, 639-48.
36. Morita, N; Hayashi, H; Ogawa, M; et al. Mechanism of ventricular fibrillation in the aged hearts exposed to glycolytic inhibition. A new model of sudden cardiac death. J Am Coll Cardiol, 2007, 49(Suppl A), 420A.
37. Kieken, F; Mutsaers, N; Dolmatova, E; Virgil, K; Wit, AL; Kellezi, A; Hirst-Jensen, BJ; Duffy, HS; Sorgen, PL. Structural and Molecular Mechanisms of Gap Junction Remodeling in Epicardial Border Zone Myocytes following Myocardial Infarction. Circ Res., 2009 Apr 2. [Epub ahead of print]
38. Qin, D; Zhang, ZH; Caref, EB; Boutjdir, M; Jain, P; el-Sherif, N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res., 1996 Sep, 79(3), 461-73.
39. Sridhar, A; Nishijima, Y; Terentyev, D; Terentyeva, R; Uelmen, R; Kukielka, M; Bonilla, IM; Robertson, GA; Györke, S; Billman, GE; Carnes, CA. Repolarization abnormalities and afterdepolarizations in a canine model of sudden cardiac death. Am J Physiol Regul Integr Comp Physiol., 2008 Nov, 295(5), R1463-72.
40. Stevenson, WG; Tedrow, U. Mapping and ablation of ventricular tachycardia after myocardial infarction (p79) in Ventricular Arrhythmias and Sudden Cardiac Death. Edited by P. Wang, H. Hsia, A. Al-Ahmad, & P. Zei. Backwell Futura. 2008, Oxford, UK. ISBN, 978-1-4051-6114-5.
41. DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation (DETERMINE) http://clinicaltrials.gov/ct2/show/NCT00487279?term=kadish+a&rank =1
42. Kirsten, HWJ; Ten Tusscher*; Alexander, V. Panfilov. Influence of diffuse fibrosis on wave propagation in human ventricular tissue. Europace, 2007, 9, vi38-vi45.
43. Lindsey, ML; Escobar, GP; Mukherjee, R; Goshorn, DK; Sheats, NJ; Bruce, JA; Mains, IM; Hendrick, JK; Hewett, KW; Gourdie, RG; Matrisian, LM; Spinale, FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation., 2006 Jun 27, 113(25), 2919-28.
44. el-Sherif, N; Gough, WB; Restivo, M. Reentrant ventricular arrhythmias in the late myocardial infarction period: 14. Mechanisms of resetting, entrainment, acceleration, or termination of reentrant tachycardia by programmed electrical stimulation. Pacing Clin Electrophysiol., 1987 Mar, 10(2), 341-71.
45. Oliveira, MM; Fiarresga, A; Pelicano, N; da Silva, N; Timóteo, AT; Carlos, I; Silva, S; Quininha, J. Temporal variations in microvolt T-wave alternans testing after acute myocardial infarction. Ann Noninvasive Electrocardiol., 2007 Apr, 12(2), 98-103.
46. Wilson, LD; Rosenbaum, DS. Mechanisms of arrythmogenic cardiac alternans. Europace., 2007 Nov, 9 Suppl 6, vi77-82.